Signal Genetics Priced, Nasdaq: SGNL
Develops and sells cancer diagnostics.
Industry: Health Care
First Day Return: -9.1%
SGNL
Develops and sells cancer diagnostics.
| IPO Data | |
|---|---|
| IPO Date | 06/17/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $9 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | New York, NY, United States |
| Founded | 2010 |
| Employees at IPO | 12 |
| Website www.signalgenetics.com | |
IPO News for Signal Genetics
Signal Genetics (SGNL) Performance
